21st Gene Forum 2022

Tartu, Estonia

September 2-3, 2022 (Hybrid meeting)

About

The Institute of Genomics of the University of Tartu and Gene Center cordially invites you to The 21st International Gene Forum 2022 on September 2-3, 2022

After two years not being able to organize a traditional conference, we are glad to announce that this year we organizing a hybrid meeting at the Estonian National Museum.

An annual international high-level scientific conference on genetics and genomics, the major event in Baltics, provides an excellent opportunity to establish and renew contacts in the region.

Due to its interdisciplinary scope, Gene Forum 2022 brings together 21 distinguished experts from Europe and US for discussion of the progress in the field. Speakers will discuss wide range of topics like personalized medicine in psychiatry, microbiome and population genomics, Parkinson disease and epigenetics.

As the organizers, we hope that the forthcoming Gene Forum 2022 will create an inspiring environment to exchange ideas and experiences. The conference will take place in Tartu, the second biggest City of Estonia, rich in academic and historical traditions. We hope that your stay in Tartu will be both enjoyable and professionally stimulating.

End of registration to the conference will be on August 25, 2022.

Register now

Programme

DAY 1
Friday, September 2nd, 2022
Time (EET) in hrs Theme Moderator Speaker Talk title
09:00 – 09:30 REGISTRATION
09:15 – 09:30 OPENING OF THE CONFERENCE Welcome by Toomas Asser, Rector, University of Tartu, Estonia
09:30 – 11:30 Personalized medicine in psychiatry Lili Milani and Kelli Lehto Professor Brenda Penninx
Amsterdam UMC
Netherlands
Using genetics to unravel the heterogeneity of depression
Professor Henrik Larsson
Karolinska Institute
Sweden
Psychiatric epidemiology using national register data: Challenges and opportunities
Dr. Christiane Gasse
Ahrus University
Denmark
Title will be confirmed
Dr. Lu Yi
Karolinska Institute
Sweden
A multidisciplinary approach to better understand treatment resistant depression
11:30 – 12:30 LUNCH BREAK
12:30 – 14:00 A tour at the Estonian National Museum
14:00 – 16:00 Immunology and Epigenetics Pärt Peterson and Ana Rebane Professor Dario Greco
University of Tampere
Finland
Integrated approaches to chemical safety assessment and drug design
Dr. Ulf Andersson Vang Orom
Aarhus University
Denmark
m6A RNA modifications, splicing and cancer
Dr. Benjamin Fairfax
University of Oxford
United Kingdom
Exploring the interplay between germline genetic variation and responses to cancer immunotherapy and chronic viral infection across a large patient cohort
Anne Puel
France
Autoimmune phenocopies of inborn errors of immunity underlying infectious diseases
16:00 – 16:30 COFFEE BREAK
16:30 – 18:30 Genetic and phenotypic variance Kaur Alasoo Dr. Claudia Langenberg
University of Cambridge/ Berlin Institute of Health at Charité
United Kingdom/Germany
From molecules to health records: utility of omics at population scale
Professor Karoline Kuchenbäcker
London’s Global University
United Kingdom
Diversity in genomic studies: the transferability of complex trait loci and its impact on downstream applications
Elo Madisson
Wellcome Sanger Institute
United Kingdom
A spatial multi-omics atlas of the human lung reveals a novel gland-associated immune niche
Ewan Birney
EMBL-EBI
United Kingdom
Big data in biology: what the pandemic has taught us
19:00 – 00:00 DINNER at Estonian National Museum
DAY 2
Saturday, September 3rd, 2022
Time (EET) in hrs Theme Moderator Speaker Talk title
09:30 – 12:00 Microbiome and population genomics Mait Metspalu and Elin Org Paul Wilmes
University of Luxembourg
Luxembourg
Systems Ecology of Human-Microbiome Interactions in Health and Disease
Leo Lahti
Univerity of Turku
Finland
Emerging computational approaches in population studies of the human microbiome
Adrian Tett
University of Vienna
Austria
The impact of Westernization on the human gut microbiome
Hannes Schroeder
University of Copenhagen
Denmark
Title will be confirmed
12:00 – 13:30 LUNCH BREAK
13:30 – 15:00 Parkinson Disease Andres Metspalu Professor Mart Saarma
University of Helsinki
Finland
Search for new molecules to cure Parkinson’s disease
Dr. Alastair Noyce
London’s Global University
United Kingdom
Determinants of Parkinson’s disease – genes, environment and interactions
Dr. Toomas Toomsoo
Confido Medical Center
Estonia
Association of the Polygenic Risk Score (PRS) With the Probability of Substantia Nigra Hyperechogenicity (SN+) in Non Parkinson’s Disease Adults” UUS ETTEPANEK: Polygenic risk score for Parkinson’s disease and probability of substantia nigra hyperechogenicity in “healthy” adults
15:00 – 15:30 COFFEE BREAK
15:30 – 17:10 Michael Simpson
Kings College London
United Kingdom
Title will be confirmed
Lisa Bastarache
Vanderbilt University Medical Center
United States of America
Studying rare variants at the population level: How EHR-linked biobanks give us new insight into monogenic disease
Presentation by Illumina To be confirmed Title to be confirmed
17:10 – 17:15 CLOSING REMARKS

Scientific Program Committee

Prof. Mait Metspalu (Chair)

Prof. Andres Metspalu

Prof. Tõnu Esko

Prof. Pärt Peterson

Prof. Ana Rebane

Lect. Kaur Alasoo

Assoc. Prof. Elin Org